PF-04523655
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for PF-04523655, covering 2012-10-11 to 2015-02-23. Get the full timeline:
Most recent: Clinical Trial Update: PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME) [Phase 2]